Fiducial Markers Market: Growing Demand to Impact Revenue Share during 2018-2028
FactMR has compiled a comprehensive study on the fiducial markers market and published a report with exclusive insights of the fiducial markers market behavior for the forecast period of 2018 to 2028.
[UKPRwire, Mon Aug 05 2019] The purpose of this comprehensive forecast report presented by Fact.MR is to elaborate the various market projections impacting the global fiducial markers market during the period through 2018-2028. This assessment delivers high-end statistics concerning market size, growth in trends and revenue share (US& Mn) linked to different geographies and segmentation types. Readers can acquire precise insights about market growth trends along with upcoming opportunities that are expected to reshape the overall structure of the fiducial markers market during the forecast period.
Request a Sample of this Report Here -https://www.factmr.com/connectus/sample?flag=S&rep_id=1026
The report on fiducial markers also features various other companies operating in the global market space. The other players profiled in the report include Innovative Oncology Solutions, Best Medical International, Inc., Carbon Medical Technologies, CIVCO, alphaXRT, Nanovi Radiotherapy A/S, and Stellar Medical. The tier 1 players in the fiducial markers market hold around 60-70% revenue share. The growth of tier 1 players can be accredited to their robust product portfolios and differentiated strategies in tune with changing nature of the market and evolving end-user specifications. With persistent focus on effective devices, offering accuracy and precision in the healthcare space, the tier 1 companies in the fiducial markers market are focused on novel product developments taking usability to the next level. Continual emphasis on product developments and innovations enables these players to retain their brand equity and solidify their sustenance in the global market space.
Fiducial markers are gaining immense traction as a standard tool for image-guided radiotherapy (IGRT), owing to enhanced precision in terms of results. Acting as reliable surrogates for effectively imaging the anatomic structures, fiducial markers are evolving as an imperative for modern radiotherapy that rapidly resorting to conformal delivery techniques. With conventional procedures overshadowing imaging accuracy, fiducial markers evolved as a new breakthrough that enabled doctors to have a target area within the field of view and ensure accurate results. In case of prostate cancer cases with floating nature of tumors, fiducial markers are being increasingly adopted for effective diagnosis with optimal accuracy and precision. The preference for minimally invasive procedures is on a continual rise by virtue of lessened pain and minimum risk of infection associated. As per a revelation by the National Health Service (NHS), cancer patients requiring radiotherapy or brachytherapy are highly oriented toward minimally invasive procedures to experience a pain-free diagnosis.
Interventions making use of fiducial markers are invasive in nature and entails a surgery for appropriate positioning of the marker, which is a key factor that might hinder the adoption rate. The increasing embracement of minimally invasive procedures is taking its toll on the adoption rate of fiducial markers, which involves an implantation procedure for target localizing.
Magnetic resonance imaging technique remains a popular technique used in case of radiology. This specialized technique necessitates use of tools and markers that are highly compatible. Many devices and markers, including fiducial markers, which are commercially sold, undergo MRI evaluations with respect to various safety issues and artifacts.
Presence of immoderate ferromagnetism that confine or obscure the target area is one of the primary reasons making commercially available devices unsuitable for MR-guided biopsy sessions. To overcome this, manufacturers are focusing on using materials with low magnetic susceptibility during manufacturing, in order to enhance compatibility of their products with MR-guided procedures. MRI compatible fiducial markers are usually longer than the standard variant, which minimizes the use of multiple needle sticks involved. Moreover, innovative designs used in case of MRI non-magnetic fiducial markers curb bending issues whilst injection processes, unlike the other linear tissue markers.
Ask Industry Experts about this Report - https://www.factmr.com/connectus/sample?flag=AE&rep_id=1026
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
11140 Rockville Pike
Suite 400, Rockville, MD 20852
Read Industry News at: https://insiderstribune.com